Challenges and opportunities for IBD drug development: from early stage to regulatory approval. Danese S, Schabel E, Ainsworth MA, Peyrin-Biroulet L, et al. Gut 2020;69:1157-1161.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Danese S, Schabel E, Ainsworth MA, Peyrin-Biroulet L, et al. Challenges and opportunities for IBD drug development: from early stage to regulatory approval. Gut 2020;69:1157-1161.
PMID: 32179569